About Crescendo Bioscience
Crescendo Bioscience is a company based in San Francisco (United States) founded in 2002 was acquired by Myriad Genetics in February 2014. Crescendo Bioscience has raised $122.05 million across 4 funding rounds from investors including Kleiner Perkins, Myriad Genetics and HHS. The company has 128 employees as of December 31, 2022. Crescendo Bioscience operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter San Francisco, United States
- Employees 128 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Crescendo Bioscience Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$122.05 M (USD)
in 4 rounds
-
Latest Funding Round
$28.45 M (USD), Series D
Dec 31, 2012
-
Investors
Kleiner Perkins
& 6 more
-
Employee Count
128
as on Dec 31, 2022
-
Acquired by
Myriad Genetics
(Feb 04, 2014)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Crescendo Bioscience
Crescendo Bioscience has successfully raised a total of $122.05M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $28.45 million completed in December 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Crescendo Bioscience
Crescendo Bioscience has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Myriad Genetics and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
US life sciences companies are invested in by Skyline Ventures.
|
Locked | Locked | Locked | |
|
Venture capital firm investing in early and growth stage companies
|
Locked | Locked | Locked | |
|
Venture capital investments are managed in technology and healthcare sectors by this firm.
|
Locked | Locked | Locked |
Investor details for Crescendo Bioscience
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Crescendo Bioscience
Investment portfolio details for Crescendo Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Crescendo Bioscience
Detailed financials for Crescendo Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Crescendo Bioscience Comparisons
Peer comparison for Crescendo Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Crescendo Bioscience
Crescendo Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are developed.
|
Detailed competitors of Crescendo Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Crescendo Bioscience
Complete news archive for Crescendo Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Crescendo Bioscience
Crescendo Bioscience was founded in 2002 and raised its 1st funding round 6 years after it was founded.
Crescendo Bioscience is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Crescendo Bioscience is a funded company, having raised a total of $122.05M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Crescendo Bioscience is 128.
Crescendo Bioscience was founded in 2002 in San Francisco, United States, as a CLIA-certified laboratory in the biotechnology sector. Molecular diagnostic tests are offered to support management of patients with autoimmune and inflammatory conditions. The Vectra DA assay, which evaluates 12 biomarkers for rheumatoid arthritis, is utilized to measure disease activity and predict therapy responses. Acquisition by Myriad Genetics occurred in February 2014 for 270 million.
Crescendo Bioscience's top competitors include Guardant Health, Exact Sciences and Foundation Medicine.
Crescendo Bioscience has 7 investors. Key investors include Kleiner Perkins, Myriad Genetics, HHS, Safeguard Scientifics, and Skyline Ventures.